SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Greg Rich who wrote (2714)10/11/1999 1:04:00 AM
From: tuck  Read Replies (3) | Respond to of 4676
 
Greg,

Some general thoughts that might guide your decison making on the short term play. You have to decide whether or not favorable PIII results are priced into the stock yet. My personal take is that it is not. The stock will rise steadily on anticipation/leaks of good results, but could sell off on the news. Friday's action, almost all retail, suggested that institutions are holding for the news, and individuals are still getting on board. Given the jump on normalish volume, imagine a big volume news driven jump. I see a few more points up before down.

Are you out of IMCL? It looks like it will continue to bounce back into the thirties. Nevertheless, you made a good -- if rather lucky -- call on IMCL's top. Good shooting. A few times this year I've been in the right security at the right time, just before freakish news broke. Perhaps, my system finds stocks waiting for a spark. And perhaps yours does, too.

Anyhow, the above is my short term guess, ceteris parabis (other things being equal). Problem is, ceteris are never parabis. I also think the market could have some more downside this year. It could dampen ISIP's performance some. Thus I'm mostly in cash, been trading puts, and dribbling money into bargains, knowing they might soon become better bargains ;~}

Cheers, Tuck (now long at 11 7/16)